Metabolomics and its potential in drug development

Biochemical Pharmacology

Volumn 85, Issue 1, 2013, Pages 12-20

  Beyoǧlu, Diren ^a   Idle, Jeffrey R ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Drug development; Metabolomics; Pharmacology; Toxicology; Ultraperformance liquid chromatography electrospray ionization quadrupole time of flight mass spectrometry

Indexed keywords

BIOLOGICAL MARKER; XENOBIOTIC AGENT;

ARTICLE; DRUG ABSORPTION; DRUG DEVELOPMENT; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG INDUSTRY; DRUG METABOLISM; EXTRACTION; GENOMICS; METABOLITE; METABOLOMICS; PHARMACOLOGY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; TOXICOLOGY; TRANSCRIPTOMICS;

EID: 84871721219     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.08.013     Document Type: Note

References (75)

1. C.H. Johnson, A.D. Patterson, J.R. Idle, and F.J. Gonzalez Xenobiotic metabolomics: major impact on the metabolome Annu Rev Pharmacol Toxicol 52 2012 37 56
2. A.D. Patterson, O. Maurhofer, D. Beyoglu, C. Lanz, K.W. Krausz, and T. Pabst Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling Cancer Res 71 2012 6590 6600
3. J.K. Nicholson, J.C. Lindon, and E. Holmes 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 29 1999 1181 1189
4. R.C. Deo, L. Hunter, G.D. Lewis, G. Pare, R.S. Vasan, and D. Chasman Interpreting metabolomic profiles using unbiased pathway models PLoS Comput Biol 6 2010 e1000692
5. J. Watrous, P. Roach, T. Alexandrov, B.S. Heath, J.Y. Yang, and R.D. Kersten Mass spectral molecular networking of living microbial colonies Proc Natl Acad Sci USA 109 2012 1743 1752
6. D.G. Robertson Metabonomics in toxicology: a review Toxicol Sci 85 2005 809 822
7. Y. Zhen, K.W. Krausz, C. Chen, J.R. Idle, and F.J. Gonzalez Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation Mol Endocrinol 21 2007 2136 2151
8. J.B. Tyburski, A.D. Patterson, K.W. Krausz, J. Slavik, A.J. Fornace Jr., and F.J. Gonzalez Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma-radiation exposure in mice Radiat Res 170 2008 1 14
9. J.B. Tyburski, A.D. Patterson, K.W. Krausz, J. Slavik, A.J. Fornace Jr., and F.J. Gonzalez Radiation metabolomics. 2. Dose- and time-dependent urinary excretion of deaminated purines and pyrimidines after sublethal gamma-radiation exposure in mice Radiat Res 172 2009 42 57
10. A.D. Patterson, O. Slanar, K.W. Krausz, F. Li, C.C. Hofer, and F. Perlik Human urinary metabolomic profile of PPARalpha induced fatty acid beta-oxidation J Proteome Res 8 2009 4293 4300
11. F. Li, A.D. Patterson, K.W. Krausz, B. Dick, F.J. Frey, and F.J. Gonzalez Metabolomics reveals the metabolic map of procainamide in humans and mice Biochem Pharmacol 83 2012 1435 1444
12. K. Schuhmann, R. Almeida, M. Baumert, R. Herzog, S.R. Bornstein, and A. Shevchenko Shotgun lipidomics on a LTQ Orbitrap mass spectrometer by successive switching between acquisition polarity modes J Mass Spectrom 47 2012 96 104
13. J.W. Allwood, D. Parker, M. Beckmann, J. Draper, and R. Goodacre Fourier transform ion cyclotron resonance mass spectrometry for plant metabolite profiling and metabolite identification Methods Mol Biol 860 2012 157 176
14. Y. Sawada, K. Akiyama, A. Sakata, A. Kuwahara, H. Otsuki, and T. Sakurai Widely targeted metabolomics based on large-scale MS/MS data for elucidating metabolite accumulation patterns in plants Plant Cell Physiol 50 2009 37 47
15. O. Fiehn, J. Kopka, R.N. Trethewey, and L. Willmitzer Identification of uncommon plant metabolites based on calculation of elemental compositions using gas chromatography and quadrupole mass spectrometry Anal Chem 72 2000 3573 3580
16. M.M. Koek, B. Muilwijk, M.J. van der Werf, and T. Hankemeier Microbial metabolomics with gas chromatography/mass spectrometry Anal Chem 78 2006 1272 1281
17. C. Lanz, A.D. Patterson, J. Slavik, K.W. Krausz, M. Ledermann, and F.J. Gonzalez Radiation metabolomics. 3. Biomarker discovery in the urine of gamma-irradiated rats using a simplified metabolomics protocol of gas chromatography-mass spectrometry combined with random forests machine learning algorithm Radiat Res 172 2009 198 212
18. R. Hall, M. Beale, O. Fiehn, N. Hardy, L. Sumner, and R. Bino Plant metabolomics: the missing link in functional genomics strategies Plant Cell 14 2002 1437 1440
19. R. Schicho, R. Shaykhutdinov, J. Ngo, A. Nazyrova, C. Schneider, and R. Panaccione Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals J Proteome Res 2012
20. D.C. Wedge, J.W. Allwood, W. Dunn, A.A. Vaughan, K. Simpson, and M. Brown Is serum or plasma more appropriate for intersubject comparisons in metabolomic studies? An assessment in patients with small-cell lung cancer Anal Chem 83 2011 6689 6697
21. K.T. Myint, T. Uehara, K. Aoshima, and Y. Oda Polar anionic metabolome analysis by nano-LC/MS with a metal chelating agent Anal Chem 81 2009 7766 7772
22. E. Mattarucchi, and C. Guillou Critical aspects of urine profiling for the selection of potential biomarkers using UPLC-TOF-MS Biomed Chromatogr 26 2011 512 517
23. R. Tautenhahn, G.J. Patti, D. Rinehart, and G. Siuzdak XCMS online a web-based platform to process untargeted metabolomic data Anal Chem 84 2012 5035 5039
24. R. Tautenhahn, C. Bottcher, and S. Neumann Highly sensitive feature detection for high resolution LC/MS BMC Bioinformatics 9 2008 504
25. M. Katajamaa, and M. Oresic Processing methods for differential analysis of LC/MS profile data BMC Bioinformatics 6 2005 179
26. X. Cai, L. Zou, J. Dong, L. Zhao, Y. Wang, and Q. Xu Analysis of highly polar metabolites in human plasma by ultra-performance hydrophilic interaction liquid chromatography coupled with quadrupole-time of flight mass spectrometry Anal Chim Acta 650 2009 10 15
27. E.J. Want, I.D. Wilson, H. Gika, G. Theodoridis, R.S. Plumb, and J. Shockcor Global metabolic profiling procedures for urine using UPLCMS Nat Protoc 5 2010 1005 1018
28. K.A. Veselkov, L.K. Vingara, P. Masson, S.L. Robinette, E. Want, and J.V. Li Optimized preprocessing of ultra-performance liquid chromatography/mass spectrometry urinary metabolic profiles for improved information recovery Anal Chem 83 2011 5864 5872
29. E. Holmes, A.W. Nicholls, J.C. Lindon, S.C. Connor, J.C. Connelly, and J.N. Haselden Chemometric models for toxicity classification based on NMR spectra of biofluids Chem Res Toxicol 13 2000 471 478
30. M.L. Anthony, B.C. Sweatman, C.R. Beddell, J.C. Lindon, and J.K. Nicholson Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine Mol Pharmacol 46 1994 199 211
31. G. Milhaud, J.N. Talbot, and G. Coutris Calcitonin treatment of post-menopausal osteoporosis. Evaluation of efficacy by principal components analysis Biomedicine 22 1975 223 232
32. A.D. Patterson, F.J. Gonzalez, and J.R. Idle Xenobiotic metabolism: a view through the metabolometer Chem Res Toxicol 23 2010 851 860
33. E. Szymanska, E. Saccenti, A.K. Smilde, and J.A. Westerhuis Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studies Metabolomics 8 2012 3 16
34. S. Giri, J.R. Idle, C. Chen, T.M. Zabriskie, K.W. Krausz, and F.J. Gonzalez A metabolomic approach to the metabolism of the areca nut alkaloids arecoline and arecaidine in the mouse Chem Res Toxicol 19 2006 818 827
35. D.S. Wishart, C. Knox, A.C. Guo, R. Eisner, N. Young, and B. Gautam HMDB: a knowledgebase for the human metabolome Nucleic Acids Res 37 2009 D603 D610
36. T.R. Sana, J.C. Roark, X. Li, K. Waddell, and S.M. Fischer Molecular formula and METLIN Personal Metabolite Database matching applied to the identification of compounds generated by LC/TOF-MS J Biomol Tech 19 2008 258 266
37. J. Draper, D.P. Enot, D. Parker, M. Beckmann, S. Snowdon, and W. Lin Metabolite signal identification in accurate mass metabolomics data with MZedDB, an interactive m/z annotation tool utilising predicted ionisation behaviour 'rules' BMC Bioinformatics 10 2009 227
38. J.L. Little, A.J. Williams, A. Pshenichnov, and V. Tkachenko Identification of known unknowns utilizing accurate mass data and ChemSpider J Am Soc Mass Spectrom 23 2012 179 185
39. T. Kind, and O. Fiehn Seven Golden Rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry BMC Bioinformatics 8 2007 105
40. J.R. Idle, and F.J. Gonzalez Metabolomics Cell Metab 6 2007 348 351
41. J. Woodcock, and R. Woosley The FDA critical path initiative and its influence on new drug development Annu Rev Med 59 2008 1 12
42. FDA 2011 novel new drugs 2012
43. C.A. Altar The Biomarkers Consortium: on the critical path of drug discovery Clin Pharmacol Ther 83 2008 361 364
44. Biomarkers Definitions Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clin Pharmacol Ther 69 2001 89 95
45. C.A. Altar, D. Amakye, D. Bounos, J. Bloom, G. Clack, and R. Dean A prototypical process for creating evidentiary standards for biomarkers and diagnostics Clin Pharmacol Ther 83 2008 368 371
46. K.C. Verhoeckx, S. Bijlsma, S. Jespersen, R. Ramaker, E.R. Verheij, and R.F. Witkamp Characterization of anti-inflammatory compounds using transcriptomics, proteomics, and metabolomics in combination with multivariate data analysis Int Immunopharmacol 4 2004 1499 1514
47. J.D. Rabinowitz, J.G. Purdy, L. Vastag, T. Shenk, and E. Koyuncu Metabolomics in drug target discovery Cold Spring Harb Symp Quant Biol 76 2011 235 246
48. T.W. Fan, P.K. Lorkiewicz, K. Sellers, H.N. Moseley, R.M. Higashi, and A.N. Lane Stable isotope-resolved metabolomics and applications for drug development Pharmacol Ther 133 2012 366 391
49. A. D'Alessandro, and L. Zolla Metabolomics and cancer drug discovery: let the cells do the talking Drug Discov Today 17 2012 3 9
50. T. Birkenstock, M. Liebeke, V. Winstel, B. Krismer, C. Gekeler, and M.J. Niemiec Exometabolome analysis identifies pyruvate dehydrogenase as a target for the antibiotic triphenylbismuthdichloride in multiresistant bacterial pathogens J Biol Chem 287 2012 2887 2895
51. R. Iyengar, S. Zhao, S.W. Chung, D.E. Mager, and J.M. Gallo Merging systems biology with pharmacodynamics Sci Transl Med 4 2012 126ps7
52. S. Zhao, and R. Iyengar Systems pharmacology: network analysis to identify multiscale mechanisms of drug action Annu Rev Pharmacol Toxicol 52 2012 505 521
53. J.R. Idle, and R.L. Smith Pharmacogenetics in the new patterns of healthcare delivery Pharmacogenetics 5 1995 347 350
54. R.P. Erickson From magic bullet to specially engineered shotgun loads: the new genetics and the need for individualized pharmacotherapy Bioessays 20 1998 683 685
55. C. Chen, F.J. Gonzalez, and J.R. Idle LCMS-based metabolomics in drug metabolism Drug Metab Rev 39 2007 581 597
56. K. Pardee, A.S. Necakov, and H. Krause Nuclear receptors small molecule sensors that coordinate growth, metabolism and reproduction Subcell Biochem 52 2011 123 153
57. S.R. Pyper, N. Viswakarma, S. Yu, and J.K. Reddy PPARalpha: energy combustion, hypolipidemia, inflammation and cancer Nucl Recept Signal 8 2010 e002
58. J.Y. Cho, T. Matsubara, D.W. Kang, S.H. Ahn, K.W. Krausz, and J.R. Idle Urinary metabolomics in Fxr-null mice reveals activated adaptive metabolic pathways upon bile acid challenge J Lipid Res 51 2010 1063 1074
59. J.B. Finkelstein FDA starts moving on critical path, but initiative running out of steam J Natl Cancer Inst 99 2007 426 427
60. D.G. Robertson, M.D. Reily, and J.D. Baker Metabonomics in preclinical drug development Expert Opin Drug Metab Toxicol 1 2005 363 376
61. D.G. Robertson, and S.J. Bulera High-throughput toxicology: practical considerations Curr Opin Drug Discov Dev 3 2000 42 47
62. D.G. Robertson, M.D. Reily, R.E. Sigler, D.F. Wells, D.A. Paterson, and T.K. Braden Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants Toxicol Sci 57 2000 326 337
63. J.P. Shockcor, and E. Holmes Metabonomic applications in toxicity screening and disease diagnosis Curr Top Med Chem 2 2002 35 51
64. 4- and alpha-naphthylisothiocyanate- induced animal models: quantitative analysis of 22 bile acids by ultraperformance liquid chromatography-mass spectrometry Chem Res Toxicol 21 2008 2280 2288
65. J.L. Griffin, and M.E. Bollard Metabonomics: its potential as a tool in toxicology for safety assessment and data integration Curr Drug Metab 5 2004 389 398
66. M. Coen A metabonomic approach for mechanistic exploration of pre-clinical toxicology Toxicology 278 2010 326 340
67. P. Masson, K. Spagou, J.K. Nicholson, and E.J. Want Technical and biological variation in UPLCMS-based untargeted metabolic profiling of liver extracts: application in an experimental toxicity study on galactosamine Anal Chem 83 2011 1116 1123
68. K. Spagou, I.D. Wilson, P. Masson, G. Theodoridis, N. Raikos, and M. Coen HILIC-UPLCMS for exploratory urinary metabolic profiling in toxicological studies Anal Chem 83 2011 382 390
69. L. Shintu, R. Baudoin, V. Navratil, J.M. Prot, C. Pontoizeau, and M. Defernez Metabolomics-on-a-chip and predictive systems toxicology in microfluidic bioartificial organs Anal Chem 84 2012 1840 1848
70. M. Zheng, X. Luo, Q. Shen, Y. Wang, Y. Du, and W. Zhu Site of metabolism prediction for six biotransformations mediated by cytochromes P450 Bioinformatics 25 2009 1251 1258
71. S.M. Paul, D.S. Mytelka, C.T. Dunwiddie, C.C. Persinger, B.H. Munos, and S.R. Lindborg How to improve R&D productivity: the pharmaceutical industry's grand challenge Nat Rev Drug Discov 9 2010 203 214
72. C.T. Caskey The drug development crisis: efficiency and safety Annu Rev Med 58 2007 1 16
73. L. Tenori, C. Oakman, W.M. Claudino, P. Bernini, S. Cappadona, and S. Nepi Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: a pilot study Mol Oncol 6 2012 437 444
74. Y. Kim, I. Koo, B.H. Jung, B.C. Chung, and D. Lee Multivariate classification of urine metabolome profiles for breast cancer diagnosis BMC Bioinformatics 11 Suppl. 2 2010 S4
75. C. Oakman, L. Tenori, L. Biganzoli, L. Santarpia, S. Cappadona, and C. Luchinat Uncovering the metabolomic fingerprint of breast cancer Int J Biochem Cell Biol 43 2011 1010 1020